246 related articles for article (PubMed ID: 31501520)
1. O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth.
Singh JP; Qian K; Lee JS; Zhou J; Han X; Zhang B; Ong Q; Ni W; Jiang M; Ruan HB; Li MD; Zhang K; Ding Z; Lee P; Singh K; Wu J; Herzog RI; Kaech S; Wendel HG; Yates JR; Han W; Sherwin RS; Nie Y; Yang X
Oncogene; 2020 Jan; 39(3):560-573. PubMed ID: 31501520
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of
Qian K; Wang S; Fu M; Zhou J; Singh JP; Li MD; Yang Y; Zhang K; Wu J; Nie Y; Ruan HB; Yang X
J Biol Chem; 2018 Sep; 293(36):13989-14000. PubMed ID: 30037904
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
6. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of O-GlcNAc cycling enzymes in human breast cancers.
Krześlak A; Forma E; Bernaciak M; Romanowicz H; Bryś M
Clin Exp Med; 2012 Mar; 12(1):61-5. PubMed ID: 21567137
[TBL] [Abstract][Full Text] [Related]
8. Feedback Regulation of
Lin CH; Liao CC; Chen MY; Chou TY
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Bolanle IO; Riches-Suman K; Williamson R; Palmer TM
Pharmacol Res; 2021 Mar; 165():105467. PubMed ID: 33515704
[TBL] [Abstract][Full Text] [Related]
10. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
[TBL] [Abstract][Full Text] [Related]
11. E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.
Muthusamy S; Hong KU; Dassanayaka S; Hamid T; Jones SP
J Biol Chem; 2015 Dec; 290(52):31013-24. PubMed ID: 26527687
[TBL] [Abstract][Full Text] [Related]
12. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
[TBL] [Abstract][Full Text] [Related]
13. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc and neurodegeneration: biochemical mechanisms and potential roles in Alzheimer's disease and beyond.
Yuzwa SA; Vocadlo DJ
Chem Soc Rev; 2014 Oct; 43(19):6839-58. PubMed ID: 24759912
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAcylation of GLI transcription factors in hyperglycemic conditions augments Hedgehog activity.
Das S; Bailey SK; Metge BJ; Hanna A; Hinshaw DC; Mota M; Forero-Torres A; Chatham JC; Samant RS; Shevde LA
Lab Invest; 2019 Feb; 99(2):260-270. PubMed ID: 30420690
[TBL] [Abstract][Full Text] [Related]
16. Gene and protein expression of O-GlcNAc-cycling enzymes in human laryngeal cancer.
Starska K; Forma E; Brzezińska-Błaszczyk E; Lewy-Trenda I; Bryś M; Jóźwiak P; Krześlak A
Clin Exp Med; 2015 Nov; 15(4):455-68. PubMed ID: 25315705
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin enhances protein
Wang D; Wu J; Wang D; Huang X; Zhang N; Shi Y
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846785
[No Abstract] [Full Text] [Related]
18. ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer.
Zhou Z; Zheng X; Zhao J; Yuan A; Lv Z; Shao G; Peng B; Dong MQ; Xu Q; Xu X; Li J
Oncogene; 2024 Jun; 43(23):1769-1778. PubMed ID: 38632437
[TBL] [Abstract][Full Text] [Related]
19. KAT2A Promotes the Succinylation of PKM2 to Inhibit its Activity and Accelerate Glycolysis of Gastric Cancer.
Zhang C; Huang Z
Mol Biotechnol; 2024 Jun; 66(6):1446-1457. PubMed ID: 37294531
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Biochemical Assays for O-GlcNAc-Processing Enzymes.
Kim EJ
Chembiochem; 2017 Aug; 18(15):1462-1472. PubMed ID: 28474822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
